DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years

Not Applicable

Terminated

Conditions: Asthma

First Posted Date: 2006-07-18

Last Posted Date: 2010-02-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 27

Registration Number: NCT00353184

Locations: 🇺🇸
St. Louis Children's Hospital, St. Louis, Missouri, United States

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

Recruiting

Conditions: Breast Neoplasms

Interventions: Procedure: Peripheral blood draw
Procedure: Breast tissue collection
Procedure: Bone marrow biopsy

First Posted Date: 2006-07-18

Last Posted Date: 2025-03-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 300

Registration Number: NCT00353483

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer

Phase 2

Terminated

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: Paclitaxel poliglumex
Drug: Carboplatin
Radiation: External beam radiation therapy

First Posted Date: 2006-07-17

Last Posted Date: 2016-12-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT00352690

Locations: 🇺🇸
University of Kansas, Lawrence, Kansas, United States
🇺🇸
Rush University Medical College, Chicago, Illinois, United States
🇺🇸
Washington Hospital Center, Washington, District of Columbia, United States

and more 5 locations

A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis

Phase 2

Terminated

Conditions: Peritoneal Neoplasms

Interventions: Procedure: Surgical debulking with peritonectomy
Drug: Intraperitoneal 5FU
Drug: FOLFOX

First Posted Date: 2006-07-17

Last Posted Date: 2016-12-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 18

Registration Number: NCT00352755

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Exercise and Testosterone Therapy in Elderly Men With Physical Frailty

Phase 3

Completed

Conditions: Hip Fracture
Physical Frailty
Elective Hip Replacement
Hypogonadism

Interventions: Drug: Transdermal Testosterone gel (1%)
Behavioral: Supervised exercise training

First Posted Date: 2006-06-29

Last Posted Date: 2018-02-22

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 25

Registration Number: NCT00345969

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients

Phase 1

Completed

Conditions: Endometrial Cancer

Interventions: Radiation: IMRT
Radiation: Intracavitary vaginal brachytherapy
Drug: Paclitaxel
Drug: Carboplatin

First Posted Date: 2006-06-07

Last Posted Date: 2015-10-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 65

Registration Number: NCT00334321

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery

Phase 2

Completed

Conditions: Deep Venous Thrombosis

Interventions: Drug: Desirudin (Iprivask™)
Drug: Heparin

First Posted Date: 2006-05-24

Last Posted Date: 2019-03-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 120

Registration Number: NCT00329433

Locations: 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States

Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer

Phase 1

Completed

Conditions: Breast Neoplasms

Interventions: Radiation: Partial Breast Irradiation (PBI)

First Posted Date: 2006-05-15

Last Posted Date: 2018-06-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 100

Registration Number: NCT00325598

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Neoplasms

Interventions: Drug: Estradiol

First Posted Date: 2006-05-10

Last Posted Date: 2015-02-16

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 66

Registration Number: NCT00324259

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

and more 4 locations

Gabapentin for the Treatment of Tinnitus

Phase 2

Terminated

Conditions: Tinnitus

First Posted Date: 2006-04-25

Last Posted Date: 2012-03-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 160

Registration Number: NCT00317850

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy